| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
7,565 |
6,151 |
$450K |
| 87507 |
|
4,478 |
3,743 |
$379K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,961 |
1,769 |
$217K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
6,688 |
2,107 |
$100K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
6,671 |
5,523 |
$68K |
| 87641 |
|
7,161 |
6,009 |
$63K |
| 87500 |
|
6,612 |
5,536 |
$52K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
722 |
624 |
$39K |
| 87506 |
|
833 |
748 |
$39K |
| 87631 |
|
365 |
310 |
$31K |
| 87481 |
|
3,838 |
2,621 |
$25K |
| 87640 |
|
3,127 |
2,637 |
$23K |
| 87653 |
|
2,733 |
2,327 |
$23K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,415 |
1,240 |
$15K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,419 |
1,240 |
$14K |
| 87486 |
|
1,175 |
992 |
$14K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,674 |
1,379 |
$13K |
| 87581 |
|
1,168 |
981 |
$13K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,427 |
1,249 |
$11K |
| 87511 |
|
1,210 |
1,062 |
$8K |
| 87625 |
|
1,238 |
1,084 |
$8K |
| 81404 |
|
922 |
136 |
$3K |
| 81321 |
|
184 |
135 |
$3K |
| 81334 |
|
182 |
133 |
$2K |
| 81235 |
|
182 |
133 |
$2K |
| 81162 |
|
173 |
124 |
$2K |
| 81272 |
|
181 |
132 |
$2K |
| 81408 |
|
346 |
124 |
$2K |
| 87799 |
|
293 |
238 |
$1K |
| 81403 |
|
366 |
136 |
$1K |
| 81401 |
|
361 |
132 |
$985.20 |
| 81407 |
|
171 |
123 |
$778.57 |
| 81201 |
|
171 |
123 |
$717.60 |
| 81317 |
|
173 |
124 |
$650.46 |
| 81292 |
|
171 |
123 |
$621.37 |
| 81298 |
|
171 |
123 |
$590.50 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$516.63 |
| 81295 |
|
171 |
123 |
$351.16 |
| 81405 |
|
348 |
124 |
$277.24 |
| 81406 |
|
346 |
124 |
$260.25 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
20 |
12 |
$186.15 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
29 |
12 |
$175.48 |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
15 |
15 |
$124.75 |
| 81209 |
|
169 |
121 |
$36.17 |
| 81242 |
|
171 |
123 |
$33.69 |
| 87471 |
|
16 |
16 |
$28.00 |
| 87529 |
|
16 |
15 |
$28.00 |
| 81345 |
|
168 |
120 |
$0.00 |
| 87532 |
|
15 |
14 |
$0.00 |